Nicoletta Loggia

Chief Tech/Sci/R&D Officer at ORCHARD THERAPEUTICS PLC

Net worth: 17 770 $ as of 30/05/2026

58 year

Health Technology

Consumer Services

Profile

Nicoletta Loggia is currently an Independent Director at Candel Therapeutics, Inc. since 2023 and Chief Technical Officer at Orchard Therapeutics Plc since 2021.
Formerly, Dr. Loggia was Head of Cell & Gene Therapies at Novartis AG from 2015 to 2021.
Education includes graduate and doctorate degrees from the University of Pavia.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CANDEL THERAPEUTICS, INC. 0%	29/06/2026	2,141 ( 0% )	17 770 $	30/05/2026

Nicoletta Loggia active positions

Companies	Position	Start
ORCHARD THERAPEUTICS PLC	Chief Tech/Sci/R&D Officer	08/09/2021
CANDEL THERAPEUTICS, INC.	Director/Board Member	06/06/2023

All active positions of Nicoletta Loggia

Former positions of Nicoletta Loggia

Companies	Position	End
NOVARTIS AG	Corporate Officer/Principal	31/07/2021

See the detail of Nicoletta Loggia's experience

Training of Nicoletta Loggia

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nicoletta Loggia's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
University of Pavia University of Pavia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Candel Therapeutics, Inc. Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer	Health Technology
Orchard Therapeutics Plc Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases	Health Technology